Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises.

International Journal of Pediatric Endocrinology
Karen J LoechnerAli S Calikoglu

Abstract

Despite decades of different treatment algorithms, the management of congenital adrenal hyperplasia (CAH) remains clinically challenging. This is due to the inherent difficulty of suppressing adrenal androgen production using near physiological dosing of glucocorticoids (GC). As a result, alternating cycles of androgen versus GC excess can occur and may lead to short stature, obesity, virilization, and alterations in puberty. Novel therapeutic alternatives, including new and more physiological means of GC delivery, inhibitors at the level of CRH or ACTH secretion and/or action, as well as "rescue strategies", such as GnRH analogs, anti-androgens, aromatase inhibitors, and estrogen receptor blockers, are available; many of these agents, however, still require active investigation in CAH. Bilateral adrenalectomy is effective but it is also still an experimental approach. Gene therapy and stem cells, to provide functional adrenal cortical tissue, are at preclinical stage but provide exciting avenues for a potential cure for CAH.

References

Dec 27, 1990·The New England Journal of Medicine·G B Cutler, L Laue
Oct 1, 1988·American Journal of Diseases of Children·M S KappyA Perelman
Oct 14, 1995·BMJ : British Medical Journal·A W AsscherV B Whitmarsh
Jul 1, 1995·The Journal of Clinical Endocrinology and Metabolism·F J CameronJ D Wark
Sep 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·S E BarrieM Jarman
Sep 1, 1993·The Journal of Clinical Endocrinology and Metabolism·P P FeuillanG B Cutler
Nov 5, 1997·The Journal of Clinical Endocrinology and Metabolism·D F GuntherJ J Van Wyk
Feb 19, 1998·Journal of Pediatric Endocrinology & Metabolism : JPEM·T TanakaI Hibi
Jun 5, 1998·Archives of Disease in Childhood·R E CorneanC G Brook
Mar 24, 2000·Endocrine-related Cancer·P FeuillanG B Cutler
Oct 25, 2000·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J W RoganG Koren
Nov 9, 2000·The New England Journal of Medicine·D P MerkeS R Bornstein
Jan 10, 2001·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J T Flynn, D A Pasko
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Salvatore AlesciMonika Ehrhart-Bornstein
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Judson J Van Wyk, E Martin Ritzen
Sep 5, 2003·Hormone Research·Peter A Lee
Oct 11, 2003·Current Drug Targets·J VoiseyA van Daal
Dec 1, 2004·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Shigeki GondoHajime Nawata
Feb 1, 2005·Journal of Pediatric Endocrinology & Metabolism : JPEM·Evangelia CharmandariDeborah P Merke
May 28, 2005·Health Communication·William Evans
Jun 21, 2005·Lancet·Deborah P Merke, Stefan R Bornstein
Jul 20, 2005·Treatments in Endocrinology·Erica A Eugster
Jan 31, 2006·Indian Journal of Pediatrics·An Tt NguyenGarry L Warne
Feb 25, 2006·European Journal of Endocrinology·Cara Megan OgilvieGerard S Conway
Apr 28, 2006·Pediatric Endocrinology Reviews : PER·Catherine Dacou-Voutetakis, Maria Dracopoulou

❮ Previous
Next ❯

Citations

Jun 4, 2011·Pharmacology & Therapeutics·H L Claahsen-van der GrintenA R M M Hermus

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
transfection

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Biosynthetic Transformations

Biosyntheic transformtions are multi-step, enzyme-catalyzed processes where substrates are converted into more complex products in living organisms. Simple compounds are modified, converted into other compounds, or joined together to form macromolecules. Discover the latest research on biosynthetic transformations here.